Received: 15 June 2021
Accepted: 19 October 2022
First Online: 4 November 2022
: The research was carried out in accordance with the relevant guidelines and regulations of the Ethics Committee of Shahid Beheshti University of Medical Sciences. The study was approved by the Ethics Committee of Shahid Beheshti University of Medical Sciences (IR.SBMU.PHARMACY.REC.1399.218), and the sampling permit was forwarded to the Iranian diabetes Association under the same code of ethics, and they gave their approval for the project. The objectives of the research were explained to the participants and an informed written consent to participate was obtained from all of them prior to beginning the research. To maintain the confidentiality of participants’ data, the questionnaires were completed anonymously with no identification number.
: Not applicable.
: All authors declare that they have no competing interests.